BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Memento EPFL//
BEGIN:VEVENT
SUMMARY:EPFL - Idorsia Joint Symposium
DTSTART:20200131T130000
DTEND:20200131T180000
DTSTAMP:20260407T130059Z
UID:9c67595db4c1967f5d4af0245c01820e481150e80879c7112dccb346
CATEGORIES:Conferences - Seminars
DESCRIPTION:EPFL: Bruno Correia\, Michele De Palma\, Bart Deplancke\, Fede
 rico Giberti\, Felix Naef\, Philippe Renaud\, Gisou van der Goot\, Martin 
 Vetterli Idorsia: Martine Clozel\, Julien Hazemann\, Cedric Leroy\, Elisa 
 Liberatore\, Christoph Sager\, Catherine Vaillant\nThe symposium aims to t
 ighten the relationship between EPFL and Idorsia\, a Basel based biopharma
 ceutical company specialized in the discovery and development of small mol
 ecules to provide innovative therapeutic possibilities. Presentations and 
 discussions will explore potential research and students collaborations.\n
 \nA unique opportunity to exchange with actors from industry. The School o
 f Life Sciences Innovation initiative Catalyze4Life encourage scientists a
 nd students interested in biopharmaceutical developments to attend.\n\nFre
 e registration required\n\nPROGRAM\n\n	13:00 Welcoming word – Gisou van 
 der Goot\, School of Life Sciences Dean\n	13:10 Welcoming word – Martine
  Clozel\, Idorsia CSO\n	13:20 'Microfluidic flow cytometry' – Philippe R
 enaud\, EPFL\n	13:40 'Leveraging Orexin receptor structures for drug desig
 n – Christoph Sager and Catherine Vaillant\, Idorsia\n	14:00 'Rational p
 rotein design driving innovation towards novel biologics and cell-based th
 erapies' – Bruno Correia\, EPFL\n	14:20 'Pyruvate Dehydrogenase Kinase (
 PDHK): a difficult to reach but appealing cancer target' – Cedric Leroy\
 , Idorsia 14:40\n	Coffee Break\n	15:20 'Perspective of industry projects f
 or Master students' – Felix Naef\, EPFL\n	15:40 'Atomistic modelling of 
 stability and properties of drug molecules with machine learning' – Fede
 rico Giberti\, EPFL\n	16:00 ‘Challenges in Maching Learning-assisted Dru
 g Design (MLDD)’ – part I – Julien Hazemann and Lisa Liberatore\, Id
 orsia\n	16:20 ‘Engineering dentritic cell vaccines for cancer immunother
 apy’ – Miki De Palma\, EPFL\n	16:40 ‘Challenges in Maching Learning-
 assisted Drug Design (MLDD)’ – part II – Julien Hazemann and Elisa L
 iberatore\, Idorsia\n	17:00 Closing comments – Martin Vetterli\, EPFL Pr
 esident\n	17:10 ‘How to strenghten ties between EPFL and Idorsia’ – 
 Discussion (on invitation only)\n	18:30 End of Symposium\n
LOCATION:SV 1717 https://plan.epfl.ch/?room==SV%201717
STATUS:CONFIRMED
END:VEVENT
END:VCALENDAR